nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abandon the NAC in α-synuclein
|
Goedert, Michel |
|
|
23 |
7 |
p. 669 |
artikel |
2 |
A call for optimal oral care in patients with ALS
|
van Selms, Maurits K A |
|
|
23 |
7 |
p. 670 |
artikel |
3 |
Amyotrophic lateral sclerosis: a lesson in translation
|
Hardiman, Orla |
|
|
23 |
7 |
p. 651-653 |
artikel |
4 |
Angela Vincent: a pioneer of immune-mediated disease
|
Morgan, Jules |
|
|
23 |
7 |
p. 671 |
artikel |
5 |
Changing the culture around dementia
|
Stirrups, Robert |
|
|
23 |
7 |
p. 673 |
artikel |
6 |
Concerns with the new biological research criteria for synucleinopathy
|
Ketchum, Fred B |
|
|
23 |
7 |
p. 659 |
artikel |
7 |
Concerns with the new biological research criteria for synucleinopathy
|
Boeve, Bradley F |
|
|
23 |
7 |
p. 659-660 |
artikel |
8 |
Concerns with the new biological research criteria for synucleinopathy
|
Arnaldi, Dario |
|
|
23 |
7 |
p. 662-663 |
artikel |
9 |
Concerns with the new biological research criteria for synucleinopathy
|
Escamilla-Sevilla, Francisco |
|
|
23 |
7 |
p. 662 |
artikel |
10 |
Concerns with the new biological research criteria for synucleinopathy
|
Goldman, Jennifer G |
|
|
23 |
7 |
p. 660-661 |
artikel |
11 |
Concerns with the new biological research criteria for synucleinopathy
|
Carli, Giulia |
|
|
23 |
7 |
p. 661 |
artikel |
12 |
Concerns with the new biological research criteria for synucleinopathy
|
Reis, Jacques |
|
|
23 |
7 |
p. 663 |
artikel |
13 |
Concerns with the new biological research criteria for synucleinopathy – Authors' reply
|
Lang, Anthony E |
|
|
23 |
7 |
p. 666-668 |
artikel |
14 |
Concerns with the new biological research criteria for synucleinopathy – Authors' reply
|
Simuni, Tanya |
|
|
23 |
7 |
p. 663-666 |
artikel |
15 |
Correction to Lancet Neurol 2024; 23: 344–81
|
|
|
|
23 |
7 |
p. e11 |
artikel |
16 |
Glioblastoma and brain connectivity: the need for a paradigm shift
|
Salvalaggio, Alessandro |
|
|
23 |
7 |
p. 740-748 |
artikel |
17 |
Hello Brain! is a welcoming head-space for all
|
Morgan, Jules |
|
|
23 |
7 |
p. 674 |
artikel |
18 |
Hemiplegic migraine in 1910
|
Weatherall, Mark |
|
|
23 |
7 |
p. 672 |
artikel |
19 |
Implementation research: an approach to overcoming the know-do gap
|
Skolarus, Lesli E |
|
|
23 |
7 |
p. 656-658 |
artikel |
20 |
Moving towards a connectomic view of neuro-oncology
|
Duffau, Hugues |
|
|
23 |
7 |
p. 655-656 |
artikel |
21 |
Multidisciplinary care for amyotrophic lateral sclerosis
|
The Lancet Neurology, |
|
|
23 |
7 |
p. 649 |
artikel |
22 |
Multiple sclerosis diagnosis: a biologically driven perspective
|
Filippi, Massimo |
|
|
23 |
7 |
p. 668-669 |
artikel |
23 |
Neurological disorders caused by novel non-coding repeat expansions: clinical features and differential diagnosis
|
Vegezzi, Elisa |
|
|
23 |
7 |
p. 725-739 |
artikel |
24 |
Progress in physical therapy for functional motor disorder
|
Hallett, Mark |
|
|
23 |
7 |
p. 650-651 |
artikel |
25 |
Recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headache
|
Petersen, Anja S |
|
|
23 |
7 |
p. 712-724 |
artikel |
26 |
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|
Benatar, Michael |
|
|
23 |
7 |
p. 687-699 |
artikel |
27 |
Safety and efficacy of stent retrievers plus contact aspiration in patients with acute ischaemic anterior circulation stroke and positive susceptibility vessel sign in France (VECTOR): a randomised, single-blind trial
|
Bourcier, Romain |
|
|
23 |
7 |
p. 700-711 |
artikel |
28 |
Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial
|
Nielsen, Glenn |
|
|
23 |
7 |
p. 675-686 |
artikel |
29 |
Susceptibility vessel sign and endovascular stroke therapy
|
Abdalkader, Mohamad |
|
|
23 |
7 |
p. 653-654 |
artikel |
30 |
Yinan “Nannan” Zhang
|
|
|
|
23 |
7 |
p. 672 |
artikel |